HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anidulafungin: experimental therapy of fungal infections in animal models].

Abstract
We have reviewed the existing data on the efficacy of anidulafungin, which is the most recent echinocandin in the experimental treatment of fungal infections. The scarce published data practically only refers to disseminated and pulmonary aspergillosis and to disseminated candidiasis. Anidulafungin shows fungistatic activity against Aspergillus fumigatus, and fungicidal activity against Candida albicans and Candida glabrata.
AuthorsFrancisco Javier Pastor, Josep Guarro
JournalRevista iberoamericana de micologia (Rev Iberoam Micol) Vol. 25 Issue 2 Pg. 119-23 (Jun 2008) ISSN: 1130-1406 [Print] Spain
Vernacular TitleAnidulafungina en el tratamiento de la infección fúngica en modelos animales.
PMID18473506 (Publication Type: Journal Article, Review)
Chemical References
  • Antifungal Agents
  • Echinocandins
  • Anidulafungin
Topics
  • Anidulafungin
  • Animals
  • Antifungal Agents (therapeutic use)
  • Aspergillosis (drug therapy)
  • Candidiasis (drug therapy)
  • Disease Models, Animal
  • Echinocandins (therapeutic use)
  • Lung Diseases, Fungal (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: